Literature DB >> 30528077

Definitive or neoadjuvant chemoradiotherapy for squamous cell oesophageal cancer?

David Ilson, Florian Lordick.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30528077     DOI: 10.1016/S1470-2045(18)30662-4

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  6 in total

Review 1.  Intratumoral Immunotherapy for Early-stage Solid Tumors.

Authors:  Wan Xing Hong; Sarah Haebe; Andrew S Lee; C Benedikt Westphalen; Jeffrey A Norton; Wen Jiang; Ronald Levy
Journal:  Clin Cancer Res       Date:  2020-02-18       Impact factor: 12.531

2.  Risk factors for anastomotic leakage after surgical resections for esophageal cancer.

Authors:  Jonas Herzberg; Tim Strate; Salman Yousuf Guraya; Human Honarpisheh
Journal:  Langenbecks Arch Surg       Date:  2021-05-15       Impact factor: 3.445

3.  A nomogram for the predicting of survival in patients with esophageal squamous cell carcinoma undergoing definitive chemoradiotherapy.

Authors:  Peiliang Wang; Maoqi Yang; Xin Wang; Zongxing Zhao; Minghuan Li; Jinming Yu
Journal:  Ann Transl Med       Date:  2021-02

Review 4.  Advances in Drug Resistance of Esophageal Cancer: From the Perspective of Tumor Microenvironment.

Authors:  Siyuan Luan; Xiaoxi Zeng; Chao Zhang; Jiajun Qiu; Yushang Yang; Chengyi Mao; Xin Xiao; Jianfeng Zhou; Yonggang Zhang; Yong Yuan
Journal:  Front Cell Dev Biol       Date:  2021-03-19

5.  Role of linear endosonography in the diagnosis of biopsy-negative malignant esophageal strictures: Exploring the unexplored.

Authors:  Amol S Dahale; Siddharth Srivastava; Ujjwal Sonika; Ashok Dalal; Aditi Goyal; Puja Sakhuja; Sanjeev Sachdeva; Amarender S Puri
Journal:  JGH Open       Date:  2019-07-18

6.  Matrix metalloproteinase-14 (MMP-14) downregulation inhibits esophageal squamous cell carcinoma cell migration, invasion, and proliferation.

Authors:  Nanzheng Chen; Guangjian Zhang; Junke Fu; Qifei Wu
Journal:  Thorac Cancer       Date:  2020-09-15       Impact factor: 3.500

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.